• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,328.19 -516.33
( -0.66%)
Global Indices
Nasdaq
49,619.91 1.93
(0.00%)
Dow Jones
7,417.79 59.68
(0.81%)
Hang Seng
62,681.30 -152.54
(-0.24%)
Nikkei 225
10,228.01 -48.94
(-0.48%)
Forex
USD-INR
94.38 -0.30
(-0.31%)
EUR-INR
110.93 -0.26
(-0.23%)
GBP-INR
128.32 -0.39
(-0.30%)
JPY-INR
0.60 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Aptus Pharma Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
544529
INE15XJ01010
29.1342566
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
291.55
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

CDSL records PAT of Rs 79.8 crore in Q4 FY26
May 02,2026

Total expenses for the period under review were Rs 163.95 crore, up 26.7% YoY.

The company posted a pre-tax profit of Rs 103.22 crore in Q4 FY26, down by 18.9% from Rs 127.20 crore in Q4 FY25.

For FY26, the bank has posted net profit and total income of Rs 455.08 crore (down 13.5% YoY) and Rs 1,144.92 crore (up 5.8% YoY), respectively.

Central Depository Services (India) (CDSL) enables the electronic holding, settlement, and transfer of securities, serving a wide range of market participants including depository participants, issuers, investors, RTAs, clearing corporations, and exchanges.

The scrip had declined 2.50% to end at Rs 1,273.80 on the NSE on Friday.